Boston Scientific Corp. (NYSE: BSX) Q4 2020 earnings call dated Feb. 03, 2021
Corporate Participants:
Susie Lisa — Vice President, Investor Relations
Michael F. Mahoney — Chairman and Chief Executive Officer
Daniel J. Brennan — Executive Vice President and Chief Financial Officer
Kenneth Stein — Senior Vice President and Chief Medical Officer, CRM
Analysts:
Robert A. Hopkins — Bank of America Merrill Lynch — Analyst
David Ryan Lewis — Morgan Stanley — Analyst
Lawrence Biegelsen — Wells Fargo Securities — Analyst
Joanne Wuensch — Citi — Analyst
Robert Marcus — J.P. Morgan — Analyst
Matthew Taylor — UBS — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
CCL Earnings: Highlights of Carnival Corporation’s Q4 2025 results
Cruise operator Carnival Corporation & plc (NYSE: CCL) on Friday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. Earnings topped analysts' expectations. Revenues
Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights
Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.
Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates
Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues
Listen On
